Fig. 1From: Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriersThe concentrations of plasma sTREM2. No change in the levels of sTREM2 between TREM2 rare variant carriers and non-carriers (a, b). A non-significant increase in sTREM2 was observed in AD patients compared to MCI and aged-matched controls (c)Back to article page